Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,712.99
(
0.28%
)
News Focus
News Focus
Post# of 257265
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 36524

Monday, 10/30/2006 12:36:44 PM

Monday, October 30, 2006 12:36:44 PM

Post# of 257265
Re: Yaron Werber

>I find it curious that Werber feels Baraclude is a best in class. Someone ought to challenge him on the basis of this statement.<

Given that Werber is forecasting $11M in Tyzeka sales for 2007 and $28M for 2008 (#msg-14371716), it’s clear to me that Werber has a motive here other than truth seeking. However, I think Werber blew it by giving Tyzeka such preposterously low sales projections as to render his entire hepatitis report suspect.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today